ARTICLE | Company News

Sirenade, Solvay structural biology deal

July 7, 2004 7:00 AM UTC

Sirenade (Munich, Germany) will use its high throughput protein crystallization technology to perform structural biology services related to an undisclosed protein from Solvay (Euronext:SOLB). Sirenade also will provide SOLB with co-crystal structures of the target protein in complex with SOLB's compounds. Sirenade will receive service payments and is eligible for milestones. ...